Trials / Unknown
UnknownNCT00767923
Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities
Clinical Validation of HyperMed OxyVu Tissue Oximeter for Assessing Level of Amputation With Comparison to Other Modalities
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- HyperMed · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Correlation of(OxyVu) values to to ABI, TBP, and TCOM in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.
Detailed description
The purpose of this clinical study is to correlate tissue oxygenation values measured with a hyperspectral imaging system (OxyVu) to Ankle Brachial Indices (ABI), toe pressures (TBP), and transcutaneous oxygen monitoring (TCOM) in patients scheduled for foot level amputation because of critical limb ischemia, infection, or tissue necrosis.
Conditions
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-02-01
- Completion
- 2010-02-01
- First posted
- 2008-10-07
- Last updated
- 2009-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00767923. Inclusion in this directory is not an endorsement.